Inner Cosmos, a neurotechnology company that implants treatment devices in human brains, said its neurostimulation technology can be used to treat depression.
The company said it has had promising findings from the initial phase of its human trials, marking a significant step forward in the treatment of treatment-resistant depression, said Meron Gribetz, CEO of Inner Cosmos, in an interview with me.
Unlock premium content and VIP community perks with GB M A X! Join now to enjoy our free and premium perks.
Join now →
Sign in to your account.